Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Thrombosis and haemostasis

Results: 1-25/490

Authors: Philipp, CS Dilley, A Saidi, P Evatt, B Austin, H Zawadsky, J Harwood, D Ellingsen, D Barnhart, E Phillips, DJ Hooper, WC
Citation: Cs. Philipp et al., Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty, THROMB HAEM, 80(6), 1998, pp. 869-873

Authors: den Heijer, M Rosendaal, FR Blom, HJ Gerrits, WBJ Bos, GMJ
Citation: M. Den Heijer et al., Hyperhomocysteinemia and venous thrombosis: A meta-analysis, THROMB HAEM, 80(6), 1998, pp. 874-877

Authors: Eikelboom, JW Baker, RI Parsons, R Taylor, RR van Bockxmeer, FM
Citation: Jw. Eikelboom et al., No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease, THROMB HAEM, 80(6), 1998, pp. 878-880

Authors: Nordt, TK Moser, M Kohler, B Ruef, J Peter, K Kubler, W Bode, C
Citation: Tk. Nordt et al., Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction, THROMB HAEM, 80(6), 1998, pp. 881-886

Authors: Gianetti, J Gensini, G De Caterina, R
Citation: J. Gianetti et al., A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy - Equivalence of costs as a possible case for oral anticoagulants, THROMB HAEM, 80(6), 1998, pp. 887-893

Authors: Shigemori, C Wada, H Matsumoto, K Shiku, H Nakamura, S Suzuki, H
Citation: C. Shigemori et al., Tissue factor expression and metastatic potential of colorectal cancer, THROMB HAEM, 80(6), 1998, pp. 894-898

Authors: Barcellona, D Vannini, ML Fenu, L Balestrieri, C Marongiu, F
Citation: D. Barcellona et al., Warfarin or acenocoumarol: Which is better in the management of oral anticoagulants?, THROMB HAEM, 80(6), 1998, pp. 899-902

Authors: Weng, XD Roederer, GO Beaulieu, R Cloutier, G
Citation: Xd. Weng et al., Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals, THROMB HAEM, 80(6), 1998, pp. 903-908

Authors: Lee, CA Ironside, JW Bell, JE Giangrande, P Ludlam, C Esiri, MM McLaughlin, JE
Citation: Ca. Lee et al., Retrospective neuropathological review of prion disease in UK haemophilic patients, THROMB HAEM, 80(6), 1998, pp. 909-911

Authors: Key, NS Aledort, LM Beardsley, D Cooper, HA Davignon, G Ewenstein, BM Gilchrist, GS Gill, JC Glader, B Hoots, WK Kisker, CT Lusher, JM Rosenfield, CG Shapiro, AD Smith, H Taft, E
Citation: Ns. Key et al., Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors, THROMB HAEM, 80(6), 1998, pp. 912-918

Authors: Goudemand, J Peynet, J Chambost, H Negrier, C Briquel, ME Claeyssens, S Derlon-Borel, A Guerois, C Caron, C Scherrmann, JM Debray, M Bridey, F
Citation: J. Goudemand et al., A cross-over pharmacokinetic study of a double viral inactivated factor IXconcentrate (15 nm filtration and SD) compared to a SD factor IX concentrate, THROMB HAEM, 80(6), 1998, pp. 919-924

Authors: Mohri, M Suzuki, M Sugimoto, E Sata, M Yamamoto, S Maruyama, I
Citation: M. Mohri et al., Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma, THROMB HAEM, 80(6), 1998, pp. 925-929

Authors: van Wijnen, M van't Veer, C Meijers, JCM Bertina, RM Bouma, BN
Citation: M. Van Wijnen et al., A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S, THROMB HAEM, 80(6), 1998, pp. 930-935

Authors: Rauch, J Tannenbaum, M Neville, C Fortin, PR
Citation: J. Rauch et al., Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin, THROMB HAEM, 80(6), 1998, pp. 936-941

Authors: Kockx, M Princen, HMG Kooistra, T
Citation: M. Kockx et al., Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-l in cultured cynomolgus monkey hepatocytes - Roleof the peroxisome proliferator-activated receptor-alpha, THROMB HAEM, 80(6), 1998, pp. 942-948

Authors: Zhao, L Morser, J Bajzar, L Nesheim, M Nagashima, M
Citation: L. Zhao et al., Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms, THROMB HAEM, 80(6), 1998, pp. 949-955

Authors: Sartori, MT Wiman, B Vettore, S Dazzi, F Girolami, A Patrassi, GM
Citation: Mt. Sartori et al., 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis, THROMB HAEM, 80(6), 1998, pp. 956-960

Authors: Camoin, L Pannell, R Anfosso, F Lefevre, JP Sampol, J Gurewich, V Dignat-George, F
Citation: L. Camoin et al., Evidence for the expression of urokinase-type plasminogen activator by human venous endothelial cells in vivo, THROMB HAEM, 80(6), 1998, pp. 961-967

Authors: Philipp, CS Remmler, J Zucker-Franklin, D
Citation: Cs. Philipp et al., The effects of Mpl-ligand, interleukin-6 and interleukin-11 on megakaryocyte and platelet alpha-granule proteins, THROMB HAEM, 80(6), 1998, pp. 968-975

Authors: Martinson, EA Scheible, S Marx-Grunwitz, A Presek, P
Citation: Ea. Martinson et al., Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets, THROMB HAEM, 80(6), 1998, pp. 976-981

Authors: Miyamoto, S Kowalska, MA Marcinkiewicz, C Marcinkiewicz, MM Mosser, D Edmunds, LH Niewiarowski, S
Citation: S. Miyamoto et al., Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates, THROMB HAEM, 80(6), 1998, pp. 982-988

Authors: Mak, KH Kottke-Marchant, K Brooks, LM Topol, EJ
Citation: Kh. Mak et al., In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blockingplatelet function in plasma of patients with heparin-induced thrombocytopenia, THROMB HAEM, 80(6), 1998, pp. 989-993

Authors: Gawaz, M Ruf, A Neumann, FJ Pogatsa-Murray, G Dickfeld, T Zohlnhofer, D Schomig, A
Citation: M. Gawaz et al., Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement, THROMB HAEM, 80(6), 1998, pp. 994-1001

Authors: Vischer, UM Emeis, JJ Bilo, HJG Stehouwer, CDA Thomsen, C Rasmussen, O Hermansen, K Wollheim, CB Ingerslev, J
Citation: Um. Vischer et al., vonWillebrand factor (vWf) as a plasma marker of endothelial activation indiabetes: Improved reliability with parallel determination of the vWf propeptide (vWf : AgII), THROMB HAEM, 80(6), 1998, pp. 1002-1007

Authors: Slupsky, JR Kalbas, M Willuweit, A Henn, V Kroczek, RA Muller-Berghaus, G
Citation: Jr. Slupsky et al., Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40, THROMB HAEM, 80(6), 1998, pp. 1008-1014
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>